Cargando…

Clinical and Immunological Effects of rhIL-2 Therapy in Eastern Chinese Patients with Multidrug-resistant Tuberculosis

It is urgent to find an optimised therapy regimen for the control of MDR-TB globally. This study aimed to evaluate the efficiacy and safety of a combined regimen of rhIL-2 injection and standard chemotherapy within 18-month duration in a randomized controlled trial conducted in 14 centres in eastern...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Qi, Min, Rui, Dai, Guan-qun, Wang, Yan-li, Nan, Li, Yang, Zhen, Xia, Jun, Pan, Shi-yang, Mao, Huang, Xie, Wei-ping, Wang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736576/ https://www.ncbi.nlm.nih.gov/pubmed/29259310 http://dx.doi.org/10.1038/s41598-017-18200-5

Ejemplares similares

Protein and Signaling Pathway Responses to rhIL-6 Intervention Before Lobaplatin Treatment in Osteosarcoma Cells
por: Wang, Huan, et al.
Publicado: (2021)

NKTR-255, a novel polymer-conjugated rhIL-15 with potent antitumor efficacy
por: Miyazaki, Takahiro, et al.
Publicado: (2021)

Identification of a Recombinant Human Interleukin-12 (rhIL-12) Fragment in Non-Reduced SDS-PAGE
por: Yu, Lei, et al.
Publicado: (2019)

Pharmacokinetic Study of rhIL-18BP and Its Effect on Radiation-Induced Cytokine Changes in Mouse Serum and Intestine
por: Cui, Wanchang, et al.
Publicado: (2022)

Quantitative phosphoproteomic analysis reveals chemoresistance-related proteins and signaling pathways induced by rhIL-6 in human osteosarcoma cells
por: Zhang, Rui, et al.
Publicado: (2021)

A Randomized Controlled Study of rhTPO and rhIL-11 for the Prophylactic Treatment of Chemotherapy-Induced Thrombocytopenia in Non-Small Cell Lung Cancer
por: Xu, Yunhua, et al.
Publicado: (2018)

Radioprotective effects of Sipunculus nudus L. polysaccharide combined with WR-2721, rhIL-11 and rhG-CSF on radiation-injured mice
por: Jiang, Shuqi, et al.
Publicado: (2015)

Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc
por: O’Neal, Julie, et al.
Publicado: (2023)

Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets
por: Sportès, Claude, et al.
Publicado: (2008)

Enhancement of recombinant human IL-24 (rhIL-24) protein production from site-specific integrated engineered CHO cells by sodium butyrate treatment
por: Hua, Jilei, et al.
Publicado: (2022)

Automation of [(18)F]fluoroacetaldehyde synthesis: application to a recombinant human interleukin‐1 receptor antagonist (rhIL‐1RA)
por: Morris, Olivia, et al.
Publicado: (2016)

A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity
por: Kim, Miriam Y., et al.
Publicado: (2022)

Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis
por: Moreland, Larry, et al.
Publicado: (2001)

CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
por: Morishima, Chihiro, et al.
Publicado: (2015)

Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma
por: Lenzi, Renato, et al.
Publicado: (2007)

Treatment outcomes for multidrug-resistant tuberculosis in Eastern Taiwan
por: Lin, Chih-Bin, et al.
Publicado: (2019)

Outbreak of multidrug-resistant tuberculosis in an aboriginal family in eastern Taiwan
por: Tang, Tao Qian, et al.
Publicado: (2016)

Associations of genotypes and haplotypes of IL-17 with risk of gastric cancer in an eastern Chinese population
por: Zhou, Fei, et al.
Publicado: (2016)

Ginsenoside Rh2 enhances the antitumor immunological response of a melanoma mice model
por: Wang, Meng, et al.
Publicado: (2017)

Single-strained DNA aptamers mask RhD antigenic epitopes on human RhD(+) red blood cells to escape alloanti-RhD immunological recognition
por: Zhang, Yinze, et al.
Publicado: (2020)

Serum IL-1β and IL-18 correlate with ESR and CRP in multidrug-resistant tuberculosis patients
por: Wang, Yanli, et al.
Publicado: (2015)

CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhil-15) is associated with robust expansion of peripheral blood CD56+ NK cells
por: Morishima, Chihiro, et al.
Publicado: (2014)

Immunological Aspects of Fulminant Type 1 Diabetes in Chinese
por: Wang, Zhen, et al.
Publicado: (2016)

Association of IL4, IL6, and IL10 polymorphisms with pulmonary tuberculosis in a Tibetan Chinese population
por: He, Shumei, et al.
Publicado: (2018)

Primary Multidrug-Resistant Mycobacterium tuberculosis in 2 Regions, Eastern Siberia, Russian Federation
por: Zhdanova, Svetlana, et al.
Publicado: (2013)

Molecular epidemiology and multidrug resistance of Mycobacterium tuberculosis complex from pulmonary tuberculosis patients in the Eastern region of Ghana
por: Thumamo Pokam, Benjamin D., et al.
Publicado: (2021)

Associations of potentially functional variants in IL-6, JAKs and STAT3 with gastric cancer risk in an eastern Chinese population
por: Zhou, Fei, et al.
Publicado: (2016)

Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition
por: Yao, Cong, et al.
Publicado: (2021)

Immunology of Tuberculosis
por: Bozzano, Federica, et al.
Publicado: (2014)

Lymphocyte-Related Immunological Indicators for Stratifying Mycobacterium tuberculosis Infection
por: Luo, Ying, et al.
Publicado: (2021)

Development of a new cellular immunological detection method for tuberculosis based on HupB protein induced IL-6 release test
por: Yu, Xiaoli, et al.
Publicado: (2023)

The multidrug resistance phenotype confers immunological resistance
Publicado: (1996)

Serum level of IL-1ra was associated with the treatment of latent tuberculosis infection in a Chinese population
por: Zhang, Haoran, et al.
Publicado: (2020)

The impact of pulmonary tuberculosis on immunological and metabolic features of diabetic patients
por: Chen, Haijun, et al.
Publicado: (2022)

Multidrug-Resistant Tuberculosis in Patients with Chronic Obstructive Pulmonary Disease in China
por: Zhao, Jiang-nan, et al.
Publicado: (2015)

Pulmonary resection in the treatment of multidrug-resistant tuberculosis: A case series
por: Wang, Lin, et al.
Publicado: (2017)

Multidrug-resistant tuberculosis
por: Zager, Ellen M, et al.
Publicado: (2008)

Multidrug-resistant tuberculosis
por: Lemos, Antônio Carlos Moreira, et al.
Publicado: (2013)

Bedaquiline and delamanid in the treatment of multidrug‐resistant tuberculosis: Promising but challenging
por: Li, Yang, et al.
Publicado: (2018)

Nomogram to predict multidrug-resistant tuberculosis
por: Wang, Saibin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ceorao8ag7p6vfao9c5rdjt88h